BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 28207517)

  • 21. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
    Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
    Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse skeletal metastasis and low thyroglobulin level in a pediatric patient with papillary thyroid carcinoma.
    Zakavi SR; Ayati N; Farahati J; Davachi B
    Indian J Nucl Med; 2015; 30(3):283-5. PubMed ID: 26170580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations.
    Giorgadze TA; Scognamiglio T; Yang GC
    Cancer Cytopathol; 2015 Feb; 123(2):71-81. PubMed ID: 25572906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Metastases of Papillary Thyroid Carcinoma with Horner's Syndrome.
    Cho SH; Kim SH; Lee JH; Joo WI; Chough CK; Park HK; Lee KJ; Rha HK
    Brain Tumor Res Treat; 2014 Oct; 2(2):132-7. PubMed ID: 25408940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma.
    Zhao CL; Qiu ZL; Chen LB; Yuan ZB; Luo QY
    Clin Nucl Med; 2013 May; 38(5):375-7. PubMed ID: 23567283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.
    Piccardo A; Arecco F; Puntoni M; Foppiani L; Cabria M; Corvisieri S; Arlandini A; Altrinetti V; Bandelloni R; Orlandi F
    Clin Nucl Med; 2013 Jan; 38(1):18-24. PubMed ID: 23242039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
    Tuttle RM; Tala H; Shah J; Leboeuf R; Ghossein R; Gonen M; Brokhin M; Omry G; Fagin JA; Shaha A
    Thyroid; 2010 Dec; 20(12):1341-9. PubMed ID: 21034228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.
    Park EK; Chung JK; Lim IH; Park DJ; Lee DS; Lee MC; Cho BY
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):172-9. PubMed ID: 18779963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar metastasis as first metastasis from papillary thyroid carcinoma.
    Pazaitou-Panayiotou K; Kaprara A; Chrisoulidou A; Boudina M; Georgiou E; Patakiouta F; Drimonitis A; Vainas I
    Endocr J; 2005 Dec; 52(6):653-7. PubMed ID: 16410655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.
    Kim TY; Kim WB; Kim ES; Ryu JS; Yeo JS; Kim SC; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1440-5. PubMed ID: 15613412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Prete SD; Squame G; Salvatore M
    Exp Mol Med; 2004 Jun; 36(3):268-73. PubMed ID: 15272239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive behaviour of solid arrangement pattern in differentiated papillary carcinoma of thyroid.
    Basu S; Nair N; Borges AM
    J Assoc Physicians India; 2003 Apr; 51():408-11. PubMed ID: 12723661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin.
    Morgenthaler NG; Froehlich J; Rendl J; Willnich M; Alonso C; Bergmann A; Reiners C
    Clin Chem; 2002 Jul; 48(7):1077-83. PubMed ID: 12089177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellopontine angle metastasis from papillary carcinoma of the thyroid: case report and literature review.
    Cha ST; Jarrahy R; Mathiesen RA; Suh R; Shahinian HK
    Surg Neurol; 2000 Oct; 54(4):320-6. PubMed ID: 11136987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
    Akslen LA; LiVolsi VA
    Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
    Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
    J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer.
    Ashcraft MW; Van Herle AJ
    Am J Med; 1981 Nov; 71(5):806-14. PubMed ID: 7304653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy.
    Carcangiu ML; Zampi G; Pupi A; Castagnoli A; Rosai J
    Cancer; 1985 Feb; 55(4):805-28. PubMed ID: 3967175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer.
    Müller-Gärtner HW; Schneider C
    Cancer; 1988 Mar; 61(5):976-81. PubMed ID: 3276396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.